⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of St. Jude Children's Research Hospital and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
St. Jude Children's Research Hospital is a premier pediatric treatment and research institution headquartered in Memphis, Tennessee. It is uniquely focused on catastrophic childhood diseases, including cancer, sickle cell disease, and other life-threatening conditions, operating as a non-profit organization where patients are not charged for care.
The institution is a designated National Cancer Institute (NCI) Comprehensive Cancer Center and maintains a robust, integrated research pipeline that bridges fundamental laboratory science with clinical application. It houses over 120 research laboratories and is known for its extensive global collaborations and commitment to sharing scientific discoveries to improve pediatric outcomes worldwide.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Pediatric Oncology and Translational Research
SIZE & FINANCIALS
Employees:10000+
Founded:1962
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Clinical
Lead Drug Stage:Phase 2/3 (Various assets)
Modalities:Small molecule, Cell therapy, Gene therapy, Vaccines
Active Trials:473
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Washington University (Pediatric Cancer Genome Project), St. Jude Global (International collaborators)
COMPETITION
Position:Leader
LINKS
Website:stjude.org
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with St. Jude Children's Research Hospital. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.